Therapeutic Trends of Cerebrovascular Disease during the COVID-19 Pandemic and Future Perspectives

키워드

참고문헌 (74)

1. Nogueira RG, "Global impact of COVID-19 on stroke care and IV thrombolysis", Neurology, 96, pp.e2824~e2838 (2021)
2. Nogueira RG, "Global impact of COVID-19 on stroke care", Int J Stroke, 16, pp.573~584 (2021)
3. Nguyen TN, "Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19pandemic", Stroke Vasc Neurol, 6, pp.542~552 (2021)
4. Siegler JE, "Cerebrovascular events and outcomes in hospitalized patients with COVID-19 : the SVIN COVID-19 Multinational Registry", Int J Stroke, 16, pp.437~447 (2021)
5. Zhao J, "Impact of the COVID-19 epidemic on stroke care and potential solutions", Stroke, 51, pp.1996~2001 (2020)
6. Kansagra AP, "Collateral effect of COVID-19 on stroke evaluation in the United States", N Engl J Med, 383, pp.400~401 (2020)
7. Ortega-Gutierrez S, "Decline in mild stroke presentations and intravenous thrombolysis during the COVID-19 pandemic : the Society of Vascular and Interventional Neurology Multicenter Collaboration", Clin Neurol Neurosurg, 201, pp.106436~ (2021)
8. Olsen SJ, "Decreased influenza activity during the COVID-19 pandemic: United States, Australia, Chile, and South Africa, 2020", MMWR Morb Mortal Wkly Rep, 69, pp.1305~1309 (2020)
9. Htun P, "Course of platelet activation and plateletleukocyte interaction in cerebrovascular ischemia", Stroke, 37, pp.2283~2287 (2006)
10. Lee KR, "Effect of influenza vaccination on risk of stroke : a systematic review and meta-analysis", Neuroepidemiology, 48, pp.103~110 (2017)
11. Lafond KE, "Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults : a systematic review and meta-analysis", PLoS Med, 18, pp.e1003550~ (2021)
12. "Research and data to make progress against the world's largest problems"[URL]
13. Yavagal DR, "International survey of mechanical thrombectomy stroke systems of care during COVID-19 pandemic", J Stroke Cerebrovasc Dis, 30, pp.105806~ (2021)
14. Srivastava PK, "Acute ischemic stroke in patients with COVID-19 : an analysis from get with the guidelines-stroke", Stroke, 52, pp.1826~1829 (2021)
15. Qureshi AI, "Acute ischemic stroke and COVID-19 : an analysis of 27 676 patients", Stroke, 52, pp.905~912 (2021)
16. de Havenon A, "Impact of COVID-19 on outcomes in ischemic stroke patients in the United States", J Stroke Cerebrovasc Dis, 30, pp.105535~ (2021)
17. Sasanejad P, "Safety and outcomes of intravenous thrombolytic therapy in ischemic stroke patients with COVID-19 : CASCADE Initiative", J Stroke Cerebrovasc Dis, 30, pp.106121~ (2021)
18. Leasure AC, "Intracerebral hemorrhage in patients with COVID-19 : an analysis from the COVID-19 Cardiovascular Disease Registry", Stroke, 52, pp.e321~e323 (2021)
19. Poyiadji N, "COVID-19-associated acute hemorrhagic necrotizing encephalopathy : imaging features", Radiology, 296, pp.E119~E120 (2020)
20. Connors JM, "COVID-19 and its implications for thrombosis and anticoagulation", Blood, 135, pp.2033~2040 (2020)
21. Henry BM, "Circulating levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are independent predictors of coronavirus disease 2019 severity: a prospective, observational study", Semin Thromb Hemost, 47, pp.451~455 (2021)
22. Rohit bhatia, "Stroke in Coronavirus Disease 2019: A Systematic Review", 대한뇌졸중영문학회지, 22(3), pp.324~335 (2020), 대한뇌졸중학회[DOI]
23. Ramos-Araque ME, "Stroke etiologies in patients with COVID-19 : the SVIN COVID-19 multinational registry", BMC Neurol, 21, pp.43~ (2021)
24. Strambo D, "Ischemic stroke in COVID-19 patients:Mechanisms, treatment, and outcomes in a consecutive Swiss Stroke Registry analysis", Eur J Neurol, 29, pp.732~743 (2022)
25. Wolter N, "Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa", bioRxiv, ~ (2021)
26. Hottz ED, "Platelet activation and plateletmonocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19", Blood, 136, pp.1330~1341 (2020)
27. Tan M, "Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China", Immunology, 160, pp.261~268 (2020)
28. Syed F, "Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19", J Infect Dis, 224, pp.60~69 (2021)
29. Velavan TP, "Mild versus severe COVID-19 : laboratory markers", Int J Infect Dis, 95, pp.304~307 (2020)
30. Manne BK, "Platelet gene expression and function in patients with COVID-19", Blood, 136, pp.1317~1329 (2020)
31. Yatim N, "Platelet activation in critically ill COVID-19 patients", Ann Intensive Care, 11, pp.113~ (2021)
32. Ma A, "Stroke and thromboprophylaxis in the era of COVID-19", J Stroke Cerebrovasc Dis, 30, pp.105392~ (2021)
33. Bonaventura A, "Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19", Nat Rev Immunol, 21, pp.319~329 (2021)
34. Lallana S, "Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19", J Clin Neurosci, 88, pp.108~112 (2021)
35. Smadja DM, "Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients", Angiogenesis, 23, pp.611~620 (2020)
36. McAlpine LS, "Ischemic stroke, inflammation, and endotheliopathy in COVID-19 patients", Stroke, 52, pp.e233~e238 (2021)
37. Varga Z, "Endothelial cell infection and endotheliitis in COVID-19", Lancet, 395, pp.1417~1418 (2020)
38. Keller E, "Large and small cerebral vessel involvement in severe COVID-19 : detailed clinical workup of a case series", Stroke, 51, pp.3719~3722 (2020)
39. Bilaloglu S, "Thrombosis in hospitalized patients with COVID-19 in a New York City health system", JAMA, 324, pp.799~801 (2020)
40. Jiménez D, "Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019 : a systematic review and meta-analysis", Chest, 159, pp.1182~1196 (2021)
41. ATTACC Investigators, "Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19", N Engl J Med, 385, pp.790~802 (2021)
42. Lopes RD, "Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial", Lancet, 397, pp.2253~2263 (2021)
43. REMAP-CAP Investigators, "Therapeutic anticoagulation with heparin in critically ill patients with COVID-19", N Engl J Med, 385, pp.777~789 (2021)
44. INSPIRATION Investigators, "Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial", JAMA, 325, pp.1620~1630 (2021)
45. Chatterjee S, "Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis", JAMA, 311, pp.2414~2421 (2014)
46. Harris SK, "Gastrointestinal hemorrhage in patients in a respiratory intensive care unit", Chest, 72, pp.301~304 (1977)
47. Nguyen TN, "Mechanical thrombectomy in the era of the COVID-19 pandemic: emergency preparedness for neuroscience teams. A guidance statement from the Society of Vascular and Interventional Neurology", Stroke, 51, pp.1896~1901 (2020)
48. Katsanos AH, "Changes in stroke hospital care during the COVID-19 pandemic : a systematic review and meta-analysis", Stroke, 52, pp.3651~3660 (2021)
49. Siegler JE, "Influence of the COVID-19 pandemic on treatment times for acute ischemic stroke : the Society of Vascular and Interventional Neurology Multicenter Collaboration", Stroke, 52, pp.40~47 (2021)
50. Plumereau C, "Effect of the COVID-19 pandemic on acute stroke reperfusion therapy : data from the Lyon Stroke Center Network", J Neurol, 268, pp.2314~2319 (2021)
51. Fuentes B, "Stroke acute management and outcomes during the COVID-19 outbreak : a cohort study from the Madrid Stroke Network", Stroke, 52, pp.552~562 (2021)
52. Chen Y, "Shortening door-to-needle time by multidisciplinary collaboration and workflow optimization during the COVID-19 pandemic", J Stroke Cerebrovasc Dis, 31, pp.106179~ (2022)
53. Hall J, "Tenecteplase improves door-to-needle time in real-world acute stroke treatment", Stroke Vasc Interv Neurol, 1, pp.e000102~ (2021)
54. Warach SJ, "Stroke thrombolysis with tenecteplase to reduce emergency department spread of coronavirus disease 2019 and shortages of alteplase", JAMA Neurol, 77, pp.1203~1204 (2020)
55. Meinel TR, "Association of initial imaging modality and futile recanalization after thrombectomy", Neurology, 95, pp.e2331~e2342 (2020)
56. Meinel TR, "Author response : association of initial imaging modality and futile recanalization after thrombectomy", Neurology, 96, pp.916~917 (2021)
57. Siegler JE, "Reader response : association of initial imaging modality and futile recanalization after thrombectomy", Neurology, 96, pp.915~916 (2021)
58. Kaesmacher J, "Mechanical thrombectomy in ischemic stroke patients with Alberta Stroke Program Early Computed Tomography Score 0-5", Stroke, 50, pp.880~888 (2019)
59. Nguyen TN, "Noncontrast computed tomography vs computed tomography perfusion or magnetic resonance imaging selection in late presentation of stroke with largevessel occlusion", JAMA Neurol, 79, pp.22~31 (2022)
60. Seker F, "Abstract TMP67 : Predictors of unfavourable events despite successful mechanical thrombectomy in the extended window", Stroke, 53(Suppl 1), pp.ATMP67~ (2022)
61. Nguyen TN, "Response by Nguyen et al to letter regarding article, "Mechanical thrombectomy in the era of the COVID-19 pandemic : emergency preparedness for neuroscience teams : a guidance statement from the society of vascular and interventional neurology"", Stroke, 51, pp.e172~e173 (2020)
62. Al Kasab S, "International experience of mechanical thrombectomy during the COVID-19 pandemic : insights from STAR and ENRG", J Neurointerv Surg, 12, pp.1039~1044 (2020)
63. Campbell D, "General anesthesia versus conscious sedation in endovascular thrombectomy for stroke : a meta-analysis of 4 randomized controlled trials", J Neurosurg Anesthesiol, 33, pp.21~27 (2021)
64. AHA, "ASA Stroke Council Leadership", Temporary emergency guidance to US stroke centers during the coronavirus disease 2019 (COVID-19) pandemic: on behalf of the American Heart Association, Stroke, pp.2020, 51[DOI]
65. Maringe C, "The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study", Lancet Oncol, 21, pp.1023~1034 (2020)
66. Williams R, "Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic : a retrospective cohort study", Lancet Public Health, 5, pp.e543~e550 (2020)
67. Sisó-Almirall A, "Impact of the COVID-19 pandemic on primary health care disease incidence rates : 2017 to 2020", Ann Fam Med, 20, pp.63~68 (2022)
68. Thau L, "Decline in rehab transfers among rehab-eligible stroke patients during the COVID-19 pandemic", J Stroke Cerebrovasc Dis, 30, pp.105857~ (2021)
69. Hatcher-Martin JM, "Telemedicine in neurology : Telemedicine Work Group of the American Academy of Neurology update", Neurology, 94, pp.30~38 (2020)
70. 남효석, "Facilitating Stroke Management using Modern Information Technology", 대한뇌졸중영문학회지, 15(3), pp.135~143 (2013), 대한뇌졸중학회[DOI]
71. Wilcock AD, "Reperfusion treatment and stroke outcomes in hospitals with telestroke capacity", JAMA Neurol, 78, pp.527~535 (2021)
72. Guzik AK, "Telestroke across the continuum of care : lessons from the COVID-19 pandemic", J Stroke Cerebrovasc Dis, 30, pp.105802~ (2021)
73. Moghimi N, "The neurological manifestations of postacute sequelae of SARS-CoV-2 infection", Curr Neurol Neurosci Rep, 21, pp.44~ (2021)
74. Yassi N, "Use of the estimand framework to manage the disruptive effects of COVID-19 on stroke clinical trials", Stroke, 52, pp.3739~3747 (2021)

관련 논문AI추천